GlassScriptPhysician profile
Bruce A Barniville
NPI 1598758104
$907.84
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $253 · 2021: $353.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $187.24 | 2019-2021 | |
| Abbvie INC. | $172.36 | 2021 | |
| Pfizer INC. | $139.07 | 2019-2021 | |
| Allergan, INC. | $72.10 | 2019-2020 | |
| Novo Nordisk INC | $55.42 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.13 | 2019-2021 | |
| Kvk-Tech, INC. | $40.33 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $39.35 | 2019 | |
| Boston Scientific Corporation | $29.20 | 2020 | |
| Merck Sharp & Dohme LLC | $19.94 | 2020 | |
| Radius Health, INC. | $18.17 | 2021 | |
| Abbott Laboratories | $16.78 | 2021 | |
| Eisai INC. | $13.39 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $13.27 | 2019 | |
| Glaxosmithkline, LLC. | $12.58 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.12 | 2019 | |
| Astellas Pharma US INC | $11.32 | 2019 | |
| Shire North American Group INC | $11.07 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Barniville listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.